{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:17:03Z","timestamp":1791515823097,"version":"4.3.4"},"publisher-location":"Cham","reference-count":229,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031627309","type":"print"},{"value":"9783031627316","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-62731-6_13","type":"book-chapter","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:02:15Z","timestamp":1721206935000},"page":"291-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers"],"prefix":"10.1007","author":[{"given":"Alexander C.","family":"Monovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Gurumurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell J. H.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, M\u00e9ar L et al (2021) A single\u2013cell type transcriptomics map of human tissues. Sci Adv 7:eabh2169","journal-title":"Sci Adv"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2018.12.036","volume":"176","author":"H Yoshida","year":"2019","unstructured":"Yoshida H, Lareau CA, Ramirez RN et al (2019) The cis-regulatory atlas of the mouse immune system. Cell 176:897\u2013912.e20","journal-title":"Cell"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/emboj.2010.106","volume":"29","author":"GH Wei","year":"2010","unstructured":"Wei GH, Badis G, Berger MF et al (2010) Genome-wide analysis of ETS-family in vitro and in vivo. EMBO J 29:2147\u20132160","journal-title":"EMBO J"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"112671","DOI":"10.1016\/j.celrep.2023.112671","volume":"42","author":"JR Terrell","year":"2023","unstructured":"Terrell JR, Taylor SJ, Schneider AL et al (2023) DNA selection by the master transcription factor PU.1. Cell Rep 42:112671","journal-title":"Cell Rep"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1182\/blood.V95.11.3341.011k44_3341_3348","volume":"95","author":"MD Potter","year":"2000","unstructured":"Potter MD, Buijs A, Kreider B et al (2000) Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1\/ETV6. Blood 95:3341\u20133348","journal-title":"Blood"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1074\/jbc.M010070200","volume":"276","author":"X Gu","year":"2001","unstructured":"Gu X, Shin B-H, Akbarali Y et al (2001) Tel-2 is a novel transcriptional repressor related to the Ets factor Tel\/ETV-6*. J Biol Chem 276:9421\u20139436","journal-title":"J Biol Chem"},{"key":"13_CR7","first-page":"871","volume":"264","author":"SR Chakrabarti","year":"1999","unstructured":"Chakrabarti SR, Nucifora G (1999) The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. BBRC 264:871\u2013877","journal-title":"BBRC"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"30132","DOI":"10.1074\/jbc.274.42.30132","volume":"274","author":"RG Lopez","year":"1999","unstructured":"Lopez RG, Carron C, Oury C et al (1999) TEL is a sequence-specific transcriptional repressor. J Biol Chem 274:30132\u201330138","journal-title":"J Biol Chem"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1128\/MCB.19.10.6566","volume":"19","author":"R Fenrick","year":"1999","unstructured":"Fenrick R, Amann JM, Lutterbach B et al (1999) Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 19:6566\u20136574","journal-title":"Mol Cell Biol"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood.V96.7.2557","volume":"96","author":"F Guidez","year":"2000","unstructured":"Guidez F, Petrie K, Ford AM et al (2000) Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96:2557\u20132561","journal-title":"Blood"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1128\/MCB.20.16.5828-5839.2000","volume":"20","author":"R Fenrick","year":"2000","unstructured":"Fenrick R, Wang L, Nip J et al (2000) TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 20:5828\u20135839","journal-title":"Mol Cell Biol"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"46378","DOI":"10.1074\/jbc.M305189200","volume":"278","author":"BJ Irvin","year":"2003","unstructured":"Irvin BJ, Wood LD, Wang L et al (2003) TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL*. J Biol Chem 278:46378\u201346386","journal-title":"J Biol Chem"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/sj.onc.1204479","volume":"20","author":"L Wang","year":"2001","unstructured":"Wang L, Hiebert SW (2001) TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20:3716\u20133725","journal-title":"Oncogene"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"15412","DOI":"10.1074\/jbc.M300592200","volume":"278","author":"P Boccuni","year":"2003","unstructured":"Boccuni P, MacGrogan D, Scandura JM et al (2003) The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). J Biol Chem 278:15412\u201315420","journal-title":"J Biol Chem"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"18496","DOI":"10.1074\/jbc.M109.096958","volume":"285","author":"SM Green","year":"2010","unstructured":"Green SM, Coyne HJ, McIntosh LP et al (2010) DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association. J Biol Chem 285:18496\u201318504","journal-title":"J Biol Chem"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.biochem.79.081507.103945","volume":"80","author":"PC Hollenhorst","year":"2011","unstructured":"Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437\u2013471","journal-title":"Annu Rev Biochem"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jmb.2012.05.010","volume":"421","author":"HJ Coyne","year":"2012","unstructured":"Coyne HJ, De S, Okon M et al (2012) Autoinhibition of ETV6 (TEL) DNA binding: appended helices sterically block the ETS domain. J Mol Biol 421:67\u201384","journal-title":"J Mol Biol"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6807-2-5","volume":"2","author":"HH Tran","year":"2002","unstructured":"Tran HH, Kim CA, Faham S et al (2002) Native interface of the SAM domain polymer of TEL. BMC Struct Biol 2:5","journal-title":"BMC Struct Biol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1093\/emboj\/20.15.4173","volume":"20","author":"CA Kim","year":"2001","unstructured":"Kim CA, Phillips ML, Kim W et al (2001) Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J 20:4173\u20134182","journal-title":"EMBO J"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0092-8674(95)90006-3","volume":"81","author":"I Rebay","year":"1995","unstructured":"Rebay I, Rubin GM (1995) Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1\/MAPK pathway. Cell 81:857\u2013866","journal-title":"Cell"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cell.2004.07.010","volume":"118","author":"F Qiao","year":"2004","unstructured":"Qiao F, Song H, Kim CA et al (2004) Derepression by depolymerization: structural insights into the regulation of Yan by Mae. Cell 118:163\u2013173","journal-title":"Cell"},{"key":"13_CR22","first-page":"116","volume":"299","author":"H Arai","year":"2002","unstructured":"Arai H, Maki K, Waga K et al (2002) Functional regulation of TEL by p38-induced phosphorylation. BBRC 299:116\u2013125","journal-title":"BBRC"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1128\/MCB.24.8.3227-3237.2004","volume":"24","author":"K Maki","year":"2004","unstructured":"Maki K, Arai H, Waga K et al (2004) Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol 24:3227\u20133237","journal-title":"Mol Cell Biol"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1128\/MCB.01159-07","volume":"28","author":"MG Roukens","year":"2008","unstructured":"Roukens MG, Alloul-Ramdhani M, Vertegaal ACO et al (2008) Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function. Mol Cell Biol 28:2342\u20132357","journal-title":"Mol Cell Biol"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1073\/pnas.0637114100","volume":"100","author":"LD Wood","year":"2003","unstructured":"Wood LD, Irvin BJ, Nucifora G et al (2003) Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc Natl Acad Sci USA 100:3257\u20133262","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1073\/pnas.240315897","volume":"97","author":"SR Chakrabarti","year":"2000","unstructured":"Chakrabarti SR, Sood R, Nandi S et al (2000) Posttranslational modification of TEL and TEL\/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc Natl Acad Sci USA 97:13281\u201313285","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1073\/pnas.96.13.7467","volume":"96","author":"SR Chakrabarti","year":"1999","unstructured":"Chakrabarti SR, Sood R, Ganguly S et al (1999) Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc Natl Acad Sci USA 96:7467\u20137472","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1128\/MCB.01914-07","volume":"28","author":"MG Roukens","year":"2008","unstructured":"Roukens MG, Alloul-Ramdhani M, Moghadasi S et al (2008) Downregulation of vertebrate Tel (ETV6) and drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination. Mol Cell Biol 28:4394\u20134406","journal-title":"Mol Cell Biol"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1128\/MCB.19.4.2624","volume":"19","author":"L Sevilla","year":"1999","unstructured":"Sevilla L, Aperlo C, Dulic V et al (1999) The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol Cell Biol 19:2624\u20132634","journal-title":"Mol Cell Biol"},{"key":"13_CR30","first-page":"668","volume":"13","author":"V Lemarchandel","year":"1993","unstructured":"Lemarchandel V, Ghysdael J, Mignotte V et al (1993) GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol 13:668\u2013676","journal-title":"Mol Cell Biol"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3177","volume":"47","author":"MY Zhang","year":"2015","unstructured":"Zhang MY, Churpek JE, Keel SB et al (2015) Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet 47:180\u2013185","journal-title":"Nat Genet"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1182\/bloodadvances.2022009313","volume":"7","author":"M Bloom","year":"2023","unstructured":"Bloom M, Oak N, Baskin-Doerfler R et al (2023) ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice. Blood Adv 7:5608. https:\/\/doi.org\/10.1182\/bloodadvances.2022009313","journal-title":"Blood Adv"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein MB, Kundaje A, Hariharan M et al (2012) Architecture of the human regulatory network derived from ENCODE data. Nature 489:91\u2013100","journal-title":"Nature"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33947-1","volume":"8","author":"B Neveu","year":"2018","unstructured":"Neveu B, Caron M, Lagac\u00e9 K et al (2018) Genome wide mapping of ETV6 binding sites in pre-B leukemic cells. Sci Rep 8:1\u20139","journal-title":"Sci Rep"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1128\/MCB.22.21.7439-7448.2002","volume":"22","author":"T Kuwata","year":"2002","unstructured":"Kuwata T, Gongora C, Kanno Y et al (2002) Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element. Mol Cell Biol 22:7439\u20137448","journal-title":"Mol Cell Biol"},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1089\/jir.2005.25.770","volume":"25","author":"Y Kanno","year":"2005","unstructured":"Kanno Y, Levi B-Z, Tamura T et al (2005) Immune cell-specific amplification of interferon signaling by the IRF-4\/8-PU.1 complex. J Interf Cytokine Res 25:770\u2013779","journal-title":"J Interf Cytokine Res"},{"key":"13_CR37","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41467-017-01070-w","volume":"8","author":"E Humblin","year":"2017","unstructured":"Humblin E, Thibaudin M, Chalmin F et al (2017) IRF8-dependent molecular complexes control the Th9 transcriptional program. Nat Commun 8:2085","journal-title":"Nat Commun"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41590-022-01374-0","volume":"24","author":"J Villar","year":"2022","unstructured":"Villar J, Cros A, De Juan A et al (2022) ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nat Immunol 24:84\u201395","journal-title":"Nat Immunol"},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1084\/jem.20172323","volume":"215","author":"CM Lau","year":"2018","unstructured":"Lau CM, Tiniakou I, Perez OA et al (2018) Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells. J Exp Med 215:2265\u20132278","journal-title":"J Exp Med"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"e140332","DOI":"10.1172\/jci.insight.140332","volume":"5","author":"MH Fisher","year":"2020","unstructured":"Fisher MH, Kirkpatrick GD, Stevens B et al (2020) ETV6 germline mutations cause HDAC3\/ NCOR2 mislocalization and upregulation of interferon response genes. JCI Insight 5:e140332","journal-title":"JCI Insight"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"e20221292","DOI":"10.1084\/jem.20221292","volume":"220","author":"R Thouenon","year":"2023","unstructured":"Thouenon R, Chentout L, Moreno-Corona N et al (2023) A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency. J Exp Med 220:e20221292","journal-title":"J Exp Med"},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"eabe1194","DOI":"10.1126\/scisignal.abe1194","volume":"14","author":"HM Froggatt","year":"2021","unstructured":"Froggatt HM, Harding AT, Chaparian RR et al (2021) ETV7 limits antiviral gene expression and control of influenza viruses. Sci Signal 14:eabe1194","journal-title":"Sci Signal"},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"38787","DOI":"10.1074\/jbc.M312581200","volume":"279","author":"N Schick","year":"2004","unstructured":"Schick N, Oakeley EJ, Hynes NE et al (2004) TEL\/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity *. J Biol Chem 279:38787\u201338796","journal-title":"J Biol Chem"},{"key":"13_CR44","doi-asserted-by":"publisher","first-page":"e23620","DOI":"10.1371\/journal.pone.0023620","volume":"6","author":"MA Meester-Smoor","year":"2011","unstructured":"Meester-Smoor MA, Janssen MJFW, ter Haar WM et al (2011) The ETS family member TEL binds to nuclear receptors RAR and RXR and represses gene activation. PLoS One 6:e23620","journal-title":"PLoS One"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"17525","DOI":"10.1074\/jbc.273.28.17525","volume":"273","author":"BA Kwiatkowski","year":"1998","unstructured":"Kwiatkowski BA, Bastian LS, Bauer TR et al (1998) The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity*. J Biol Chem 273:17525\u201317530","journal-title":"J Biol Chem"},{"key":"13_CR46","first-page":"285","volume":"25","author":"DY Lu","year":"2023","unstructured":"Lu DY, Ellegast JM, Ross KN et al (2023) The ETS transcription factor ETV6 constrains the transcriptional activity of EWS\u2013FLI to promote Ewing sarcoma. Nat Cell Biol 25:285\u2013297","journal-title":"Nat Cell Biol"},{"key":"13_CR47","first-page":"298","volume":"25","author":"Y Gao","year":"2023","unstructured":"Gao Y, He X-Y, Wu XS et al (2023) ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Nat Cell Biol 25:298\u2013308","journal-title":"Nat Cell Biol"},{"key":"13_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2643-3230.BCD-21-0224","volume":"4","author":"R Kodgule","year":"2023","unstructured":"Kodgule R, Goldman JW, Monovich AC et al (2023) ETV6 deficiency unlocks ERG-dependent microsatellite enhancers to drive aberrant gene activation in B-lymphoblastic leukemia. Blood Cancer Discov 4:34\u201353","journal-title":"Blood Cancer Discov"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1073\/pnas.0801073105","volume":"105","author":"K Gangwal","year":"2008","unstructured":"Gangwal K, Sankar S, Hollenhorst PC et al (2008) Microsatellites as EWS\/FLI response elements in Ewing\u2019s sarcoma. Proc Natl Acad Sci USA 105:10149\u201310154","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR50","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","volume":"26","author":"N Riggi","year":"2014","unstructured":"Riggi N, Knoechel B, Gillespie SM et al (2014) EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell 26:668\u2013681","journal-title":"Cancer Cell"},{"key":"13_CR51","doi-asserted-by":"crossref","unstructured":"Unnikrishnan A, Guan YF, Huang Y et al (2016) A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network. Nucleic Acids Res 44:10644\u201310661","DOI":"10.1093\/nar\/gkw804"},{"key":"13_CR52","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41467-019-09050-y","volume":"10","author":"L Li","year":"2019","unstructured":"Li L, Rispoli R, Patient R et al (2019) Etv6 activates VEGFA expression through positive and negative transcriptional regulatory networks in Xenopus embryos. Nat Commun 10:1083","journal-title":"Nat Commun"},{"key":"13_CR53","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1093\/emboj\/16.14.4374","volume":"16","author":"LC Wang","year":"1997","unstructured":"Wang LC, Kuo F, Fujiwara Y et al (1997) Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J 16:4374\u20134383","journal-title":"EMBO J"},{"key":"13_CR54","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1101\/gad.12.15.2392","volume":"12","author":"LC Wang","year":"1998","unstructured":"Wang LC, Swat W, Fujiwara Y et al (1998) The TEL\/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 12:2392\u20132402","journal-title":"Genes Dev"},{"key":"13_CR55","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1101\/gad.1239604","volume":"18","author":"H Hock","year":"2004","unstructured":"Hock H, Meade E, Medeiros S et al (2004) Tel\/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev 18:2336\u20132341","journal-title":"Genes Dev"},{"key":"13_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stem.2013.05.024","volume":"13","author":"C-F Pereira","year":"2013","unstructured":"Pereira C-F, Chang B, Qiu J et al (2013) Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13:205\u2013218","journal-title":"Cell Stem Cell"},{"key":"13_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.devcel.2010.02.009","volume":"18","author":"A Ciau-Uitz","year":"2010","unstructured":"Ciau-Uitz A, Pinheiro P, Gupta R et al (2010) Tel1\/ETV6 specifies blood stem cells through the agency of VEGF signaling. Dev Cell 18:569\u2013578","journal-title":"Dev Cell"},{"key":"13_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","volume":"151","author":"M Ciofani","year":"2012","unstructured":"Ciofani M, Madar A, Galan C et al (2012) A validated regulatory network for Th17 cell specification. Cell 151:289\u2013303","journal-title":"Cell"},{"key":"13_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","volume":"16","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Metzger ML, Wu G et al (2015) Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Lancet Oncol 16:1659\u20131666","journal-title":"Lancet Oncol"},{"key":"13_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ng.3253","volume":"47","author":"L Noetzli","year":"2015","unstructured":"Noetzli L, Lo RW, Lee-Sherick AB et al (2015) Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet 47:535\u2013538","journal-title":"Nat Genet"},{"key":"13_CR61","doi-asserted-by":"publisher","first-page":"e1005262","DOI":"10.1371\/journal.pgen.1005262","volume":"11","author":"S Topka","year":"2015","unstructured":"Topka S, Vijai J, Walsh MF et al (2015) Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia. PLoS Genet 11:e1005262","journal-title":"PLoS Genet"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3324\/haematol.2016.147496","volume":"101","author":"F Melazzini","year":"2016","unstructured":"Melazzini F, Palombo F, Balduini A et al (2016) Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia. Haematologica 101:1333\u20131342","journal-title":"Haematologica"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3324\/haematol.2016.147694","volume":"102","author":"M Poggi","year":"2017","unstructured":"Poggi M, Canault M, Favier M et al (2017) Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors. Haematologica 102:282\u2013294","journal-title":"Haematologica"},{"key":"13_CR64","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1182\/blood.2019852418","volume":"134","author":"J Di Paola","year":"2019","unstructured":"Di Paola J, Porter CC (2019) ETV6-related thrombocytopenia and leukemia predisposition. Blood 134:663\u2013667","journal-title":"Blood"},{"key":"13_CR65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.seminhematol.2017.04.005","volume":"54","author":"H Hock","year":"2017","unstructured":"Hock H, Shimamura A (2017) ETV6 in hematopoiesis and leukemia predisposition. Semin Hematol 54:98\u2013104","journal-title":"Semin Hematol"},{"key":"13_CR66","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1182\/blood.2020006164","volume":"137","author":"R Nishii","year":"2021","unstructured":"Nishii R, Baskin-Doerfler R, Yang W et al (2021) Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. Blood 137:364\u2013373","journal-title":"Blood"},{"key":"13_CR67","first-page":"1298","volume":"142","author":"M McConville","year":"2023","unstructured":"McConville M, Thomas T, Valadez C et al (2023) Familial thrombocytopenia-associated germline ETV6 P214L mutation results in XPO1-mediated nuclear export. Blood [65th ASH Annual Meeting Abstracts] 142:1298","journal-title":"Blood [65th ASH Annual Meeting Abstracts]"},{"key":"13_CR68","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/10428194.2017.1359742","volume":"59","author":"V Dirse","year":"2018","unstructured":"Dirse V, Norvilas R, Gineikiene E et al (2018) ETV6 and NOTCH1 germline variants in adult acute leukemia. Leuk Lymphoma 59:1022\u20131024","journal-title":"Leuk Lymphoma"},{"key":"13_CR69","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/bloodadvances.2018028795","volume":"3","author":"T J\u00e4rviaho","year":"2019","unstructured":"J\u00e4rviaho T, Bang B, Zachariadis V et al (2019) Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6. Blood Adv 3:2722\u20132731","journal-title":"Blood Adv"},{"key":"13_CR70","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.stemcr.2021.04.013","volume":"16","author":"S Borst","year":"2021","unstructured":"Borst S, Nations CC, Klein JG et al (2021) Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Rep 16:1458\u20131467","journal-title":"Stem Cell Rep"},{"key":"13_CR71","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1016\/j.jtha.2023.04.007","volume":"21","author":"T Bigot","year":"2023","unstructured":"Bigot T, Gabinaud E, Hannouche L et al (2023) Single-cell analysis of megakaryopoiesis in peripheral CD34+ cells: insights into ETV6-related thrombocytopenia. J Thromb Haemost 21:2528\u20132544","journal-title":"J Thromb Haemost"},{"key":"13_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(00)00017-0","volume":"13","author":"A Hart","year":"2000","unstructured":"Hart A, Melet F, Grossfeld P et al (2000) Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13:167\u2013177","journal-title":"Immunity"},{"key":"13_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exphem.2022.06.002","volume":"112\u2013113","author":"C Zhou","year":"2022","unstructured":"Zhou C, Uluisik R, Rowley JW et al (2022) Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors. Exp Hematol 112\u2013113:24\u201334","journal-title":"Exp Hematol"},{"key":"13_CR74","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","volume":"99","author":"J Cools","year":"2002","unstructured":"Cools J, Mentens N, Odero MD et al (2002) Evidence for position effects as a variantETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood 99:1776\u20131784","journal-title":"Blood"},{"key":"13_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-015-0041-4","volume":"3","author":"S Tosi","year":"2015","unstructured":"Tosi S, Mostafa Kamel Y, Owoka T et al (2015) Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects. Biomark Res 3:21","journal-title":"Biomark Res"},{"key":"13_CR76","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/gcc.20335","volume":"45","author":"ARM von Bergh","year":"2006","unstructured":"von Bergh ARM, van Drunen E, van Wering ER et al (2006) High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression ofHLXB9. Genes Chromosomes Cancer 45:731\u2013739","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR77","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41417-019-0159-x","volume":"27","author":"T Wang","year":"2020","unstructured":"Wang T, Chen X, Hui S et al (2020) Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12). Cancer Gene Ther 27:810\u2013818","journal-title":"Cancer Gene Ther"},{"key":"13_CR78","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z et al (2022) The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet 54:1376\u20131389","journal-title":"Nat Genet"},{"key":"13_CR79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/gcc.2870090307","volume":"9","author":"SP Romana","year":"1994","unstructured":"Romana SP, Coniat ML, Berger R (1994) t( 12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186\u2013191","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR80","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","volume":"86","author":"S Romana","year":"1995","unstructured":"Romana S, Poirel H, Leconiat M et al (1995) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263\u20134269","journal-title":"Blood"},{"key":"13_CR81","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1073\/pnas.92.11.4917","volume":"92","author":"TR Golub","year":"1995","unstructured":"Golub TR, Barker GF, Bohlander SK et al (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917\u20134921","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR82","first-page":"1985","volume":"9","author":"SA Shurtleff","year":"1995","unstructured":"Shurtleff SA, Buijs A, Behm FG et al (1995) TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985\u20131989","journal-title":"Leukemia"},{"key":"13_CR83","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000356778","volume":"132","author":"C Hahm","year":"2014","unstructured":"Hahm C, Han SH, Mun YC et al (2014) ETV6\/RUNX1 rearrangement identified by RT-PCR without evidence on FISH. Acta Haematol 132:122\u2013124","journal-title":"Acta Haematol"},{"key":"13_CR84","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3324\/haematol.2022.282498","volume":"108","author":"SB Mueller","year":"2023","unstructured":"Mueller SB, Pikman Y, Tasian SK et al (2023) ETV6 fusions from insertions of exons 3-5 in pediatric hematologic malignancies. Haematologica 108:3471\u20133476","journal-title":"Haematologica"},{"key":"13_CR85","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/sj.leu.2403706","volume":"19","author":"M Vaskova","year":"2005","unstructured":"Vaskova M, Mejstrikova E, Kalina T et al (2005) Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia. Leukemia 19:876\u2013878","journal-title":"Leukemia"},{"key":"13_CR86","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","volume":"102","author":"ME Ross","year":"2003","unstructured":"Ross ME, Zhou X, Song G et al (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951\u20132959","journal-title":"Blood"},{"key":"13_CR87","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","volume":"2","author":"S Jeha","year":"2021","unstructured":"Jeha S, Choi J, Roberts KG et al (2021) Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease\u2013directed therapy. Blood Cancer Discov 2:326\u2013337","journal-title":"Blood Cancer Discov"},{"key":"13_CR88","first-page":"1094","volume":"96","author":"NLR Woerden","year":"2000","unstructured":"Woerden NLR, Pieters R, Loonen AH et al (2000) TEL\/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 96:1094\u20131099","journal-title":"Blood"},{"key":"13_CR89","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1182\/blood-2003-12-4426","volume":"104","author":"B-M Frost","year":"2004","unstructured":"Frost B-M, Forestier E, Gustafsson G et al (2004) Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood 104:2452\u20132457","journal-title":"Blood"},{"key":"13_CR90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","volume":"29","author":"SHR Lee","year":"2023","unstructured":"Lee SHR, Yang W, Gocho Y et al (2023) Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. Nat Med 29:170\u2013179","journal-title":"Nat Med"},{"key":"13_CR91","doi-asserted-by":"publisher","first-page":"e30585","DOI":"10.1002\/pbc.30585","volume":"70","author":"EA Raetz","year":"2023","unstructured":"Raetz EA, Bhojwani D, Devidas M et al (2023) Children\u2019s Oncology Group blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer 70:e30585","journal-title":"Pediatr Blood Cancer"},{"key":"13_CR92","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","volume":"34","author":"R Pieters","year":"2016","unstructured":"Pieters R, de Groot-Kruseman H, Van der Velden V et al (2016) Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group. J Clin Oncol 34:2591\u20132601","journal-title":"J Clin Oncol"},{"key":"13_CR93","doi-asserted-by":"publisher","first-page":"639479","DOI":"10.3389\/fped.2021.639479","volume":"9","author":"EL Marcotte","year":"2021","unstructured":"Marcotte EL, Spector LG, Mendes-de-Almeida DP et al (2021) The prenatal origin of childhood leukemia: potential applications for epidemiology and newborn screening. Front Pediatr 9:639479","journal-title":"Front Pediatr"},{"key":"13_CR94","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","volume":"129","author":"M de Bruijn","year":"2017","unstructured":"de Bruijn M, Dzierzak E (2017) Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129:2061\u20132069","journal-title":"Blood"},{"key":"13_CR95","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/13793","volume":"23","author":"W-J Song","year":"1999","unstructured":"Song W-J, Sullivan MG, Legare RD et al (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166\u2013175","journal-title":"Nat Genet"},{"key":"13_CR96","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bcmd.2010.02.009","volume":"44","author":"M Lichtinger","year":"2010","unstructured":"Lichtinger M, Hoogenkamp M, Krysinska H et al (2010) Chromatin regulation by RUNX1. Blood Cells Mol Dis 44:287\u2013290","journal-title":"Blood Cells Mol Dis"},{"key":"13_CR97","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1038\/s41467-022-34653-3","volume":"13","author":"JP Wray","year":"2022","unstructured":"Wray JP, Deltcheva EM, Boiers C et al (2022) Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability. Nat Commun 13:7124","journal-title":"Nat Commun"},{"key":"13_CR98","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1101\/gr.193649.115","volume":"26","author":"S Teppo","year":"2016","unstructured":"Teppo S, Laukkanen S, Liuksiala T et al (2016) Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia. Genome Res 26:1468\u20131477","journal-title":"Genome Res"},{"key":"13_CR99","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1128\/MCB.16.4.1349","volume":"16","author":"SW Hiebert","year":"1996","unstructured":"Hiebert SW, Sun W, Davis JN et al (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349\u20131355","journal-title":"Mol Cell Biol"},{"key":"13_CR100","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1182\/blood.V94.3.1057.415k10_1057_1062","volume":"94","author":"JL Wiemels","year":"1999","unstructured":"Wiemels JL, Ford AM, Van Wering ER et al (1999) Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 94:1057\u20131062","journal-title":"Blood"},{"key":"13_CR101","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/blood.V98.2.478","volume":"98","author":"AT Maia","year":"2001","unstructured":"Maia AT, Ford AM, Jalali GR et al (2001) Molecular tracking of leukemogenesis in a triplet pregnancy. Blood 98:478\u2013482","journal-title":"Blood"},{"key":"13_CR102","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1073\/pnas.95.8.4584","volume":"95","author":"AM Ford","year":"1998","unstructured":"Ford AM, Bennett CA, Price CM et al (1998) Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 95:4584\u20134588","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR103","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","volume":"354","author":"JL Wiemels","year":"1999","unstructured":"Wiemels JL, Cazzaniga G, Daniotti M et al (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354:1499\u20131503","journal-title":"Lancet"},{"key":"13_CR104","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/gcc.10199","volume":"37","author":"CM McHale","year":"2003","unstructured":"McHale CM, Wiemels JL, Zhang L et al (2003) Prenatal origin of \u2121-AML1\u2013positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 37:36\u201343","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR105","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1182\/blood.V99.8.2992","volume":"99","author":"JW Taub","year":"2002","unstructured":"Taub JW, Konrad MA, Ge Y et al (2002) High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 99:2992\u20132996","journal-title":"Blood"},{"key":"13_CR106","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/gcc.20010","volume":"40","author":"AT Maia","year":"2004","unstructured":"Maia AT, Tussiwand R, Cazzaniga G et al (2004) Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood. Genes Chromosomes Cancer 40:38\u201343","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR107","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/leu.2008.152","volume":"22","author":"B Gruhn","year":"2008","unstructured":"Gruhn B, Taub JW, Ge Y et al (2008) Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy. Leukemia 22:1692\u20131697","journal-title":"Leukemia"},{"key":"13_CR108","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood.V97.3.737","volume":"97","author":"M Eguchi-Ishimae","year":"2001","unstructured":"Eguchi-Ishimae M, Eguchi M, Ishii E et al (2001) Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 97:737\u2013743","journal-title":"Blood"},{"key":"13_CR109","doi-asserted-by":"publisher","first-page":"8242","DOI":"10.1073\/pnas.112218799","volume":"99","author":"H Mori","year":"2002","unstructured":"Mori H, Colman SM, Xiao Z et al (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 99:8242\u20138247","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR110","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","volume":"131","author":"D Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer D, Olsen M, L\u00e4hnemann D et al (2018) Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood 131:821\u2013826","journal-title":"Blood"},{"key":"13_CR111","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1182\/bloodadvances.2023009808","volume":"7","author":"MNE Sommarin","year":"2023","unstructured":"Sommarin MNE, Olofzon R, Palo S et al (2023) Single-cell multiomics of human fetal hematopoiesis define a developmental-specific population and a fetal signature. Blood Adv 7:5325\u20135340","journal-title":"Blood Adv"},{"key":"13_CR112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/blood-2023-174139","volume":"142","author":"Z Li","year":"2023","unstructured":"Li Z, Chang T-C, Junco JJ et al (2023) Genomic landscape of Down syndrome\u2013associated acute lymphoblastic leukemia. Blood 142:172\u2013184","journal-title":"Blood"},{"key":"13_CR113","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-023-02810-1","volume":"42","author":"G Sharma","year":"2023","unstructured":"Sharma G, Tran TM, Bansal I et al (2023) RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia. J Exp Clin Cancer Res 42:231","journal-title":"J Exp Clin Cancer Res"},{"key":"13_CR114","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2003-10-3695","volume":"103","author":"M Morrow","year":"2004","unstructured":"Morrow M, Horton S, Kioussis D et al (2004) TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 103:3890\u20133896","journal-title":"Blood"},{"key":"13_CR115","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-4608(01)00518-0","volume":"130","author":"P Andreasson","year":"2001","unstructured":"Andreasson P, Schwaller J, Anastasiadou E et al (2001) The expression of ETV6\/CBFA2 (TEL\/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet 130:93\u2013104","journal-title":"Cancer Genet Cytogenet"},{"key":"13_CR116","doi-asserted-by":"publisher","first-page":"19069","DOI":"10.1073\/pnas.0506637102","volume":"102","author":"A Andersson","year":"2005","unstructured":"Andersson A, Olofsson T, Lindgren D et al (2005) Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci USA 102:19069\u201319074","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR117","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1593\/neo.131310","volume":"15","author":"H-P Kantner","year":"2013","unstructured":"Kantner H-P, Warsch W, Delogu A et al (2013) ETV6\/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells. Neoplasia 15:1292\u20131300","journal-title":"Neoplasia"},{"key":"13_CR118","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.stem.2009.04.019","volume":"5","author":"JW Schindler","year":"2009","unstructured":"Schindler JW, Van Buren D, Foudi A et al (2009) TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 5:43\u201353","journal-title":"Cell Stem Cell"},{"key":"13_CR119","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1182\/blood-2011-02-338848","volume":"118","author":"L van der Weyden","year":"2011","unstructured":"van der Weyden L, Giotopoulos G, Rust AG et al (2011) Modeling the evolution of ETV6-RUNX1\u2013induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 118:1041\u20131051","journal-title":"Blood"},{"key":"13_CR120","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1038\/sj.onc.1210227","volume":"26","author":"M Morrow","year":"2007","unstructured":"Morrow M, Samanta A, Kioussis D et al (2007) TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL. Oncogene 26:4404\u20134414","journal-title":"Oncogene"},{"key":"13_CR121","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/stem.1277","volume":"31","author":"S Tsuzuki","year":"2013","unstructured":"Tsuzuki S, Seto M (2013) TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice. Stem Cells 31:236\u2013247","journal-title":"Stem Cells"},{"key":"13_CR122","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1038\/sj.onc.1208931","volume":"24","author":"M Fischer","year":"2005","unstructured":"Fischer M, Schwieger M, Horn S et al (2005) Defining the oncogenic function of the TEL\/AML1 (ETV6\/RUNX1) fusion protein in a mouse model. Oncogene 24:7579\u20137591","journal-title":"Oncogene"},{"key":"13_CR123","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.1073\/pnas.0402063101","volume":"101","author":"S Tsuzuki","year":"2004","unstructured":"Tsuzuki S, Seto M, Greaves M et al (2004) Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 101:8443\u20138448","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR124","first-page":"826","volume":"119","author":"AM Ford","year":"2009","unstructured":"Ford AM, Palmi C, Bueno C et al (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-\u03b2 pathway in early B lineage progenitor cells. J Clin Invest 119:826\u2013836","journal-title":"J Clin Invest"},{"key":"13_CR125","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/onc.2014.148","volume":"34","author":"D Fan","year":"2015","unstructured":"Fan D, Zhou X, Li Z et al (2015) Stem cell programs are retained in human leukemic lymphoblasts. Oncogene 34:2083\u20132093","journal-title":"Oncogene"},{"key":"13_CR126","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ng.2874","volume":"46","author":"E Papaemmanuil","year":"2014","unstructured":"Papaemmanuil E, Rapado I, Li Y et al (2014) RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet 46:116\u2013125","journal-title":"Nat Genet"},{"key":"13_CR127","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ni.3160","volume":"16","author":"S Swaminathan","year":"2015","unstructured":"Swaminathan S, Klemm L, Park E et al (2015) Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia. Nat Immunol 16:766\u2013774","journal-title":"Nat Immunol"},{"key":"13_CR128","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-genet-072920-035840","volume":"56","author":"TM Mertz","year":"2022","unstructured":"Mertz TM, Collins CD, Dennis M et al (2022) APOBEC-induced mutagenesis in cancer. Annu Rev Genet 56:229\u2013252","journal-title":"Annu Rev Genet"},{"key":"13_CR129","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1038\/s41467-019-13570-y","volume":"10","author":"G Rodr\u00edguez-Hern\u00e1ndez","year":"2019","unstructured":"Rodr\u00edguez-Hern\u00e1ndez G, Opitz FV, Delgado P et al (2019) Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat Commun 10:5563","journal-title":"Nat Commun"},{"key":"13_CR130","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1038\/ncomms9866","volume":"6","author":"S Kasar","year":"2015","unstructured":"Kasar S, Kim J, Improgo R et al (2015) Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat Commun 6:8866","journal-title":"Nat Commun"},{"key":"13_CR131","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-022-05072-7","volume":"608","author":"HE Machado","year":"2022","unstructured":"Machado HE, Mitchell E, \u00d8bro NF et al (2022) Diverse mutational landscapes in human lymphocytes. Nature 608:724\u2013732","journal-title":"Nature"},{"key":"13_CR132","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1158\/0008-5472.CAN-17-0701","volume":"77","author":"G Rodr\u00edguez-Hern\u00e1ndez","year":"2017","unstructured":"Rodr\u00edguez-Hern\u00e1ndez G, Hauer J, Mart\u00edn-Lorenzo A et al (2017) Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases. Cancer Res 77:4365\u20134377","journal-title":"Cancer Res"},{"key":"13_CR133","first-page":"704591","volume":"9","author":"G Rodr\u00edguez-Hern\u00e1ndez","year":"2021","unstructured":"Rodr\u00edguez-Hern\u00e1ndez G, Casado-Garc\u00eda A, Isidro-Hern\u00e1ndez M et al (2021) The second oncogenic hit determines the cell fate of ETV6-RUNX1 positive. Leukemia 9:704591","journal-title":"Leukemia"},{"key":"13_CR134","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1150648","volume":"319","author":"D Hong","year":"2008","unstructured":"Hong D, Gupta R, Ancliff P et al (2008) Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 319:336\u2013339","journal-title":"Science"},{"key":"13_CR135","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.devcel.2017.12.005","volume":"44","author":"C B\u00f6iers","year":"2018","unstructured":"B\u00f6iers C, Richardson SE, Laycock E et al (2018) A human IPS model implicates embryonic B-myeloid fate restriction as developmental susceptibility to B acute lymphoblastic leukemia-associated ETV6-RUNX1. Dev Cell 44:362\u2013377.e7","journal-title":"Dev Cell"},{"key":"13_CR136","first-page":"5377","volume":"55","author":"S Takeuchi","year":"1995","unstructured":"Takeuchi S, Bartram CR, Wada M et al (1995) Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 55:5377\u20135382","journal-title":"Cancer Res"},{"key":"13_CR137","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1182\/blood.V86.4.1525.bloodjournal8641525","volume":"86","author":"Y Sato","year":"1995","unstructured":"Sato Y, Suto Y, Pietenpol J et al (1995) TEL and KIP1 define the smallest region of deletions on 12pl3 in hematopoietic malignancies. Blood 86:1525\u20131533","journal-title":"Blood"},{"key":"13_CR138","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1182\/blood.V86.10.3869.bloodjournal86103869","volume":"86","author":"H Cave","year":"1995","unstructured":"Cave H, Gerard B, Martin E et al (1995) Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1. Blood 86:3869\u20133875","journal-title":"Blood"},{"key":"13_CR139","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood.V86.1.38.bloodjournal86138","volume":"86","author":"K Stegmaier","year":"1995","unstructured":"Stegmaier K, Pendse S, Barker GF et al (1995) Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86:38\u201344","journal-title":"Blood"},{"key":"13_CR140","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood.V88.3.785.785","volume":"88","author":"DH Kim","year":"1996","unstructured":"Kim DH, Moldwin RL, Vignon C et al (1996) TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 88:785\u2013794","journal-title":"Blood"},{"key":"13_CR141","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood.V87.7.2891.bloodjournal8772891","volume":"87","author":"S Raynaud","year":"1996","unstructured":"Raynaud S, Cave H, Baens M et al (1996) The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891\u20132899","journal-title":"Blood"},{"key":"13_CR142","first-page":"623","volume":"322","author":"H Gunji","year":"2004","unstructured":"Gunji H, Waga K, Nakamura F et al (2004) TEL\/AML1 shows dominant-negative effects over TEL as well as AML1. BBRC 322:623\u2013630","journal-title":"BBRC"},{"key":"13_CR143","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.xgen.2023.100442","volume":"3","author":"KR Barnett","year":"2023","unstructured":"Barnett KR, Mobley RJ, Diedrich JD et al (2023) Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. Cell Genom 3:100442","journal-title":"Cell Genom"},{"key":"13_CR144","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1182\/blood-2011-05-354266","volume":"118","author":"V Torrano","year":"2011","unstructured":"Torrano V, Procter J, Cardus P et al (2011) ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood 118:4910\u20134918","journal-title":"Blood"},{"key":"13_CR145","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccell.2015.12.013","volume":"29","author":"I Iacobucci","year":"2016","unstructured":"Iacobucci I, Li Y, Roberts KG et al (2016) Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia. Cancer Cell 29:186\u2013200","journal-title":"Cancer Cell"},{"key":"13_CR146","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3324\/haematol.2018.193631","volume":"104","author":"R Polak","year":"2019","unstructured":"Polak R, Bierings MB, van der Leije CS et al (2019) Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Haematologica 104:738\u2013748","journal-title":"Haematologica"},{"key":"13_CR147","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebj\u00f6rn","year":"2016","unstructured":"Lilljebj\u00f6rn H, Henningsson R, Hyrenius-Wittsten A et al (2016) Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun 7:11790","journal-title":"Nat Commun"},{"key":"13_CR148","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/gcc.22464","volume":"56","author":"M Zaliova","year":"2017","unstructured":"Zaliova M, Kotrova M, Bresolin S et al (2017) ETV6\/RUNX1-like acute lymphoblastic leukemia: a novel B-cell precursor leukemia subtype associated with the CD27\/CD44 immunophenotype. Genes Chromosomes Cancer 56:608\u2013616","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR149","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG et al (2019) PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296\u2013307","journal-title":"Nat Genet"},{"key":"13_CR150","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","volume":"37","author":"SL Ryan","year":"2023","unstructured":"Ryan SL, Peden JF, Kingsbury Z et al (2023) Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia. Leukemia 37:518\u2013528","journal-title":"Leukemia"},{"key":"13_CR151","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ng.2754","volume":"45","author":"S Shah","year":"2013","unstructured":"Shah S, Schrader KA, Waanders E et al (2013) A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 45:1226\u20131231","journal-title":"Nat Genet"},{"key":"13_CR152","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/leu.2013.363","volume":"28","author":"F Auer","year":"2014","unstructured":"Auer F, R\u00fcschendorf F, Gombert M et al (2014) Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A. Leukemia 28:1136\u20131138","journal-title":"Leukemia"},{"key":"13_CR153","first-page":"4666","volume":"61","author":"G Cazzaniga","year":"2001","unstructured":"Cazzaniga G, Daniotti M, Tosi S et al (2001) The paired box domain gene PAX5 is fused to ETV6\/TEL in an acute lymphoblastic leukemia case. Cancer Res 61:4666\u20134670","journal-title":"Cancer Res"},{"key":"13_CR154","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/sj.leu.2402923","volume":"17","author":"S Strehl","year":"2003","unstructured":"Strehl S, K\u00f6nig M, Dworzak MN et al (2003) PAX5\/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia 17:1121\u20131123","journal-title":"Leukemia"},{"key":"13_CR155","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I et al (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758\u2013764","journal-title":"Nature"},{"key":"13_CR156","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1158\/0008-5472.CAN-07-2778","volume":"68","author":"G Fazio","year":"2008","unstructured":"Fazio G, Palmi C, Rolink A et al (2008) PAX5\/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. Cancer Res 68:181\u2013189","journal-title":"Cancer Res"},{"key":"13_CR157","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/onc.2011.291","volume":"31","author":"N Kawamata","year":"2012","unstructured":"Kawamata N, Pennella MA, Woo JL et al (2012) Dominant-negative mechanism of leukemogenic PAX5 fusions. Oncogene 31:966\u2013977","journal-title":"Oncogene"},{"key":"13_CR158","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/leu.2012.281","volume":"27","author":"G Fazio","year":"2013","unstructured":"Fazio G, Cazzaniga V, Palmi C et al (2013) PAX5\/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5. Leukemia 27:992\u2013995","journal-title":"Leukemia"},{"key":"13_CR159","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood.2019004381","volume":"136","author":"C Vicente-Due\u00f1as","year":"2020","unstructured":"Vicente-Due\u00f1as C, Janssen S, Oldenburg M et al (2020) An intact gut microbiome protects genetically predisposed mice against leukemia. Blood 136:2003\u20132017","journal-title":"Blood"},{"key":"13_CR160","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D et al (2014) Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371:1005\u20131015","journal-title":"N Engl J Med"},{"key":"13_CR161","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-022-03402-8","volume":"482","author":"A Tzankov","year":"2023","unstructured":"Tzankov A, Reichard KK, Hasserjian RP et al (2023) Updates on eosinophilic disorders. Virchows Arch 482:85\u201397","journal-title":"Virchows Arch"},{"key":"13_CR162","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/his.15021","volume":"83","author":"L Saft","year":"2023","unstructured":"Saft L, Kvasnicka HM, Boudova L et al (2023) Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: a workshop report with focus on novel entities and a literature review including paediatric cases. Histopathology 83:829\u2013849","journal-title":"Histopathology"},{"key":"13_CR163","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub TR, Barker GF, Lovett M et al (1994) Fusion of PDGF receptor \u03b2 to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307\u2013316","journal-title":"Cell"},{"key":"13_CR164","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1128\/MCB.16.8.4107","volume":"16","author":"TR Golub","year":"1996","unstructured":"Golub TR, Goga A, Barker GF et al (1996) Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107\u20134116","journal-title":"Mol Cell Biol"},{"key":"13_CR165","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1128\/MCB.24.11.4685-4695.2004","volume":"24","author":"RP Million","year":"2004","unstructured":"Million RP, Harakawa N, Roumiantsev S et al (2004) A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. Mol Cell Biol 24:4685\u20134695","journal-title":"Mol Cell Biol"},{"key":"13_CR166","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/sj.onc.1208588","volume":"24","author":"S Barjesteh van Waalwijk van Doorn-Kh","year":"2005","unstructured":"Barjesteh van Waalwijk van Doorn-Khosrovani S, Spensberger D, de Knegt Y et al (2005) Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene 24:4129\u20134137","journal-title":"Oncogene"},{"key":"13_CR167","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar R, Stevenson K, Abdel-Wahab O et al (2011) Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496\u20132506","journal-title":"N Engl J Med"},{"key":"13_CR168","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3324\/haematol.2014.104406","volume":"99","author":"Q Wang","year":"2014","unstructured":"Wang Q, Dong S, Yao H et al (2014) ETV6 mutation in a cohort of 970 patients with hematologic malignancies. Haematologica 99:e176\u2013e178","journal-title":"Haematologica"},{"issue":"2","key":"13_CR169","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bjh.18850","volume":"202","author":"M Gurney","year":"2023","unstructured":"Gurney M, Chekkaf I, Baranwal A et al (2023) The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. Br J Haematol 202(2):279\u2013283","journal-title":"Br J Haematol"},{"key":"13_CR170","doi-asserted-by":"publisher","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","volume":"1","author":"E Bernard","year":"2022","unstructured":"Bernard E, Tuechler H, Greenberg PL et al (2022) Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 1:EVIDoa2200008","journal-title":"NEJM Evid"},{"key":"13_CR171","first-page":"188389","volume":"1874","author":"A Biswas","year":"2020","unstructured":"Biswas A, Rajesh Y, Mitra P et al (2020) ETV6 gene aberrations in non-haematological malignancies: a review highlighting ETV6 associated fusion genes in solid tumors. Biochim Biophys Acta 1874:188389","journal-title":"Biochim Biophys Acta"},{"key":"13_CR172","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1182\/bloodadvances.2020003737","volume":"5","author":"MW Perez","year":"2021","unstructured":"Perez MW, Sias-Garcia O, Daramola A et al (2021) Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency. Blood Adv 5:4864\u20134876","journal-title":"Blood Adv"},{"key":"13_CR173","doi-asserted-by":"crossref","unstructured":"Xu W, Tian F, Tai X, et al (2024) ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression. Online ahead of print","DOI":"10.3324\/haematol.2023.284121"},{"key":"13_CR174","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/leu.2009.15","volume":"23","author":"E Ballabio","year":"2009","unstructured":"Ballabio E, Cantarella CD, Federico C et al (2009) Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias. Leukemia 23:1179\u20131182","journal-title":"Leukemia"},{"key":"13_CR175","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/ijc.34122","volume":"151","author":"T Nilsson","year":"2022","unstructured":"Nilsson T, Waraky A, \u00d6stlund A et al (2022) An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages. Int J Cancer 151:770\u2013778","journal-title":"Int J Cancer"},{"key":"13_CR176","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2007-03-080523","volume":"110","author":"M Heuser","year":"2007","unstructured":"Heuser M, Argiropoulos B, Kuchenbauer F et al (2007) MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 110:1639\u20131647","journal-title":"Blood"},{"key":"13_CR177","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1182\/blood-2014-04-564666","volume":"124","author":"S Imren","year":"2014","unstructured":"Imren S, Heuser M, Gasparetto M et al (2014) Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13. Blood 124:3608\u20133612","journal-title":"Blood"},{"key":"13_CR178","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.molcel.2021.04.014","volume":"81","author":"SS Riedel","year":"2021","unstructured":"Riedel SS, Lu C, Xie HM et al (2021) Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. Mol Cell 81:2332\u20132348.e9","journal-title":"Mol Cell"},{"key":"13_CR179","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ccr.2011.06.020","volume":"20","author":"M Heuser","year":"2011","unstructured":"Heuser M, Yun H, Berg T et al (2011) Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1\/AbdB-like HOX protein complex. Cancer Cell 20:39\u201352","journal-title":"Cancer Cell"},{"key":"13_CR180","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI80825","volume":"126","author":"SS Riedel","year":"2016","unstructured":"Riedel SS, Haladyna JN, Bezzant M et al (2016) MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. J Clin Invest 126:1438\u20131450","journal-title":"J Clin Invest"},{"key":"13_CR181","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41375-021-01146-z","volume":"35","author":"C Libbrecht","year":"2021","unstructured":"Libbrecht C, Xie HM, Kingsley MC et al (2021) Menin is necessary for long term maintenance of meningioma-1 driven leukemia. Leukemia 35:1405\u20131417","journal-title":"Leukemia"},{"key":"13_CR182","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI129126","volume":"130","author":"S Klossowski","year":"2020","unstructured":"Klossowski S, Miao H, Kempinska K et al (2020) Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Invest 130:981\u2013997","journal-title":"J Clin Invest"},{"key":"13_CR183","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa GC, Aldoss I, DiPersio J et al (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615:920\u2013924","journal-title":"Nature"},{"key":"13_CR184","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M et al (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10:147\u2013156","journal-title":"Lancet Oncol"},{"key":"13_CR185","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A et al (2011) ETV6 mutations in early immature human T cell leukemias. J Exp Med 208:2571\u20132579","journal-title":"J Exp Med"},{"key":"13_CR186","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L et al (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157\u2013163","journal-title":"Nature"},{"key":"13_CR187","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","volume":"19","author":"I Homminga","year":"2011","unstructured":"Homminga I, Pieters R, Langerak AW et al (2011) Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19:484\u2013497","journal-title":"Cancer Cell"},{"key":"13_CR188","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1158\/1078-0432.CCR-07-4022","volume":"14","author":"S Strehl","year":"2008","unstructured":"Strehl S, Nebral K, K\u00f6nig M et al (2008) ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res 14:977\u2013983","journal-title":"Clin Cancer Res"},{"key":"13_CR189","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/blood.2020010405","volume":"139","author":"H Fishman","year":"2022","unstructured":"Fishman H, Madiwale S, Geron I et al (2022) ETV6-NCOA2 fusion induces T\/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells. Blood 139:399\u2013412","journal-title":"Blood"},{"key":"13_CR190","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24:679\u2013690","journal-title":"Nat Med"},{"key":"13_CR191","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW et al (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378:1396\u20131407","journal-title":"N Engl J Med"},{"key":"13_CR192","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-22-0561","volume":"13","author":"L Venturutti","year":"2023","unstructured":"Venturutti L, Rivas MA, Pelzer BW et al (2023) An aged\/autoimmune B-cell program defines the early transformation of extranodal lymphomas. Cancer Discov 13:216\u2013243","journal-title":"Cancer Discov"},{"key":"13_CR193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/2643-3230.BCD-19-0059","volume":"2","author":"R Fl\u00fcmann","year":"2021","unstructured":"Fl\u00fcmann R, Rehk\u00e4mper T, Nieper P et al (2021) An autochthonous mouse model of Myd88- and BCL2-driven diffuse large B-cell lymphoma reveals actionable molecular vulnerabilities. Blood Cancer Discov 2:70\u201391","journal-title":"Blood Cancer Discov"},{"key":"13_CR194","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1158\/2643-3230.BCD-22-0007","volume":"4","author":"R Fl\u00fcmann","year":"2023","unstructured":"Fl\u00fcmann R, Hansen J, Pelzer BW et al (2023) Distinct genetically determined origins of Myd88\/BCL2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discov 4:78\u201397","journal-title":"Blood Cancer Discov"},{"key":"13_CR195","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","volume":"13","author":"J Radke","year":"2022","unstructured":"Radke J, Ishaque N, Koll R et al (2022) The genomic and transcriptional landscape of primary central nervous system lymphoma. Nat Commun 13:2558","journal-title":"Nat Commun"},{"key":"13_CR196","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MGM, Stewart C et al (2016) Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 127:869\u2013881","journal-title":"Blood"},{"key":"13_CR197","first-page":"1598","volume":"6","author":"I Bonzheim","year":"2022","unstructured":"Bonzheim I, Sander P, Salmer\u00f3n-Villalobos J et al (2022) The molecular hallmarks of primary and secondary vitreoretinal lymphoma. Blood Adv 6:1598\u20131607","journal-title":"Blood Adv"},{"key":"13_CR198","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1182\/bloodadvances.2022006985","volume":"6","author":"R Kodgule","year":"2022","unstructured":"Kodgule R, Chen J, Khonde P et al (2022) Recurrent switch 2 domain RAC2 mutations in intravascular large B-cell lymphoma. Blood Adv 6:6051\u20136055","journal-title":"Blood Adv"},{"key":"13_CR199","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/PAS.0000000000001978","volume":"47","author":"B Gonzalez-Farre","year":"2023","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Castrej\u00f3n de Anta N et al (2023) Intravascular large B-cell lymphoma genomic profile is characterized by alterations in genes regulating NF-\u03baB and immune checkpoints. Am J Surg Pathol 47:202","journal-title":"Am J Surg Pathol"},{"key":"13_CR200","doi-asserted-by":"publisher","first-page":"188389","DOI":"10.1016\/j.bbcan.2020.188389","volume":"1874","author":"A Biswas","year":"2020","unstructured":"Biswas A, Rajesh Y, Mitra P et al (2020) ETV6 gene aberrations in non-haematological malignancies: a review highlighting ETV6 associated fusion genes in solid tumors. Biochim Biophys Acta Rev Cancer 1874:188389","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"13_CR201","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ng0298-184","volume":"18","author":"SR Knezevich","year":"1998","unstructured":"Knezevich SR, McFadden DE, Tao W et al (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184\u2013187","journal-title":"Nat Genet"},{"key":"13_CR202","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/00000478-200007000-00005","volume":"24","author":"JM Bourgeois","year":"2000","unstructured":"Bourgeois JM, Knezevich SR, Mathers JA et al (2000) Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital Fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol 24:937","journal-title":"Am J Surg Pathol"},{"key":"13_CR203","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1309\/3H24-E7T7-V37G-AKKQ","volume":"115","author":"WQ Sheng","year":"2001","unstructured":"Sheng WQ, Hisaoka M, Okamoto S et al (2001) Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol 115:348\u2013355","journal-title":"Am J Clin Pathol"},{"key":"13_CR204","doi-asserted-by":"crossref","unstructured":"Vokuhl C, Nourkami-Tutdibi N, Furtw\u00e4ngler R et al (2018) ETV6-NTRK3 in congenital mesoblastic nephroma: a report of the SIOP\/GPOH nephroblastoma study. Pediatr Blood Cancer 65:e26925","DOI":"10.1002\/pbc.26925"},{"key":"13_CR205","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0002-9440(10)65732-X","volume":"153","author":"BP Rubin","year":"1998","unstructured":"Rubin BP, Chen CJ, Morgan TW et al (1998) Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 153:1451\u20131458","journal-title":"Am J Pathol"},{"key":"13_CR206","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G, Diaz AK, Paugh BS et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444\u2013450","journal-title":"Nat Genet"},{"key":"13_CR207","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tranon.2018.02.020","volume":"11","author":"T Xu","year":"2018","unstructured":"Xu T, Wang H, Huang X et al (2018) Gene fusion in malignant glioma: an emerging target for next-generation personalized treatment. Transl Oncol 11:609\u2013618","journal-title":"Transl Oncol"},{"key":"13_CR208","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/EJE-17-0499","volume":"178","author":"AU Bastos","year":"2018","unstructured":"Bastos AU, de Jesus AC, Cerutti JM (2018) ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. Eur J Endocrinol 178:83\u201391","journal-title":"Eur J Endocrinol"},{"key":"13_CR209","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/PAS.0000000000000814","volume":"41","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Chiosea SI, Liu CZ et al (2017) Clinical and morphologic features of ETV6-NTRK3 translocated papillary thyroid carcinoma in an adult population without radiation exposure. Am J Surg Pathol 41:446\u2013457","journal-title":"Am J Surg Pathol"},{"key":"13_CR210","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/cncr.28484","volume":"120","author":"RJ Leeman-Neill","year":"2014","unstructured":"Leeman-Neill RJ, Kelly LM, Liu P et al (2014) ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer 120:799\u2013807","journal-title":"Cancer"},{"key":"13_CR211","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","volume":"2","author":"C Tognon","year":"2002","unstructured":"Tognon C, Knezevich SR, Huntsman D et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367\u2013376","journal-title":"Cancer Cell"},{"key":"13_CR212","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","volume":"83","author":"J Guilmette","year":"2019","unstructured":"Guilmette J, Dias-Santagata D, Nos\u00e9 V et al (2019) Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol 83:50\u201358","journal-title":"Hum Pathol"},{"key":"13_CR213","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/PAS.0000000000000734","volume":"41","author":"JA Bishop","year":"2017","unstructured":"Bishop JA, Taube JM, Su A et al (2017) Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands. Am J Surg Pathol 41:62","journal-title":"Am J Surg Pathol"},{"key":"13_CR214","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/sj.onc.1203396","volume":"19","author":"DH Wai","year":"2000","unstructured":"Wai DH, Knezevich SR, Lucas T et al (2000) The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 19:906\u2013915","journal-title":"Oncogene"},{"key":"13_CR215","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","volume":"40","author":"AH Alassiri","year":"2016","unstructured":"Alassiri AH, Ali RH, Shen Y et al (2016) ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors. Am J Surg Pathol 40:1051","journal-title":"Am J Surg Pathol"},{"key":"13_CR216","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/his.12910","volume":"69","author":"H Yamamoto","year":"2016","unstructured":"Yamamoto H, Yoshida A, Taguchi K et al (2016) ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology 69:72\u201383","journal-title":"Histopathology"},{"key":"13_CR217","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M et al (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45:580\u2013585","journal-title":"Nat Genet"},{"key":"13_CR218","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Tissue-based map of the human proteome. Science 347:1260419","journal-title":"Science"},{"key":"13_CR219","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar S et al (2020) Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol 21:531\u2013540","journal-title":"Lancet Oncol"},{"key":"13_CR220","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele RC, Drilon A, Paz-Ares L et al (2020) Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet Oncol 21:271\u2013282","journal-title":"Lancet Oncol"},{"key":"13_CR221","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","volume":"42","author":"A Skalova","year":"2018","unstructured":"Skalova A, Vanecek T, Martinek P et al (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42:234\u2013246","journal-title":"Am J Surg Pathol"},{"key":"13_CR222","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12105-019-01074-6","volume":"14","author":"M Black","year":"2020","unstructured":"Black M, Liu CZ, Onozato M et al (2020) Concurrent identification of novel EGFR-SEPT14 fusion and ETV6-RET fusion in secretory carcinoma of the salivary gland. Head Neck Pathol 14:817\u2013821","journal-title":"Head Neck Pathol"},{"key":"13_CR223","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/PAS.0000000000001065","volume":"42","author":"LM Rooper","year":"2018","unstructured":"Rooper LM, Karantanos T, Ning Y et al (2018) Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular Spectrum of a recently described entity. Am J Surg Pathol 42:1121","journal-title":"Am J Surg Pathol"},{"key":"13_CR224","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/modpathol.2017.191","volume":"31","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Swanson D, Charames GS et al (2018) Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. Mod Pathol 31:753\u2013762","journal-title":"Mod Pathol"},{"key":"13_CR225","doi-asserted-by":"publisher","first-page":"9912","DOI":"10.1073\/pnas.1921333117","volume":"117","author":"S Lee","year":"2020","unstructured":"Lee S, Hu Y, Loo SK et al (2020) Landscape analysis of adjacent gene rearrangements reveals BCL2L14\u2013ETV6 gene fusions in more aggressive triple-negative breast cancer. Proc Natl Acad Sci USA 117:9912\u20139921","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR226","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"The UniProt Consortium","year":"2021","unstructured":"The UniProt Consortium (2021) UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 49:D480\u2013D489","journal-title":"Nucleic Acids Res"},{"key":"13_CR227","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ejh.12981","volume":"100","author":"N Duployez","year":"2018","unstructured":"Duployez N, Abou Chahla W, Lejeune S et al (2018) Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia. Eur J Haematol 100:104\u2013107","journal-title":"Eur J Haematol"},{"key":"13_CR228","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.3324\/haematol.2018.205849","volume":"104","author":"SV Junk","year":"2019","unstructured":"Junk SV, Klein N, Schreek S et al (2019) TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia. Haematologica 104:e402\u2013e405","journal-title":"Haematologica"},{"key":"13_CR229","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/09537104.2020.1802416","volume":"32","author":"KS Kozubik","year":"2021","unstructured":"Kozubik KS, Radova L, Reblova K et al (2021) Functional analysis of germline ETV6 W380R mutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia. Platelets 32:838\u2013841","journal-title":"Platelets"}],"container-title":["Advances in Experimental Medicine and Biology","Transcription factors in blood cell development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-62731-6_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:02:49Z","timestamp":1721206969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-62731-6_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031627309","9783031627316"],"references-count":229,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-62731-6_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"18 July 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}